CompletedNCT02649231
Ketamine and Therapy to Reduce Alcohol Relapse
About this title
Read the official source — NCT02649231Medication studyAges 18–60United KingdomAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 60 years.
- Listed locations
- Exeter and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: October 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 96
- Sponsor
- University College, London
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United Kingdom
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT02649231
- Official title
Show the full official title
A Phase II, Randomised, Double-blind, Placebo- Controlled, Multi-site, Parallel Group Clinical Trial to Examine Ketamine as a Pharmacological Treatment for Alcohol Dependence in an Alcohol Dependent Population
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Exeter · London
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University College, London, a university.
Did this study involve medication?
Yes. The study involved medication, including ketamine and Placebo.
Who was this study for?
Listed age limits: 18 years to 60 years.
